Toddler Infected With Rare Side Effect Of Smallpox Vaccination Recovering
...r. Kahana recalled.
The doctors worked with the Food and Drug Administration to allow the use of an experimental drug for smallpox, ST-246, from siga
Technologies, which appeared to begin turning the case around.
Meanwhile, doctors drained the boys distended abdomen and cut away the dead skin,...
Immune function could benefit from exercise
...etermine the role of stress on immune function, was tested before training and at 4 and 12 months after training. Researchers found that the levels of siga
increased with exercise and as the time of exercise increased, so, too, did the levels of SIgA. The researchers thus concluded that regular moderate e...
SIGA in Medical Technology
Albemarle Optimizes Smallpox Drug Candidate for SIGA
Fine Chemistry Services unit demonstrates pilot production for "fast track" drug
BATON ROUGE, La., May 5 /PRNewswire-FirstCall/ -- Two American
companies are teaming up for second-round test-phase production of a
FDA-designated "fast track" drug candidate to trea...
SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
... NEW YORK--(BUSINESS WIRE)--May 15, 2007 - siga
(NASDAQ: SIGA) announced today ... what is seen in
human Lassa fever infections, and siga
expects that this model is
one of the two animal m...National
Institutes of Health (NIH), which awarded siga
a $6.0 million grant
in September 2006.
SIGA in Biological Technology
Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthene's Legal Action in Breach of Contract Lawsuit Against SIGA
ANNAPOLIS, Md., Jan. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc.,
(Amex: PIP ) a biodefense company developing medical countermeasures against
biological and chemical threats, announced that the Delaware Chancery Court
today issued a ruling denying a motion by SIGA
Technologies to dismiss
Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development
...utics, Emergent BioSolutions, Hematech, Inc., a subsidiary of Kyowa Kirin, Human Genome Sciences, Inc., NanoViricides, Inc., Pfizer Inc., PharmAthene, siga
Technologies, and Unither Virology LLC, a subsidiary of United Therapeutics.
Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
...ces, who also serves as Chief Executive Officer of siga
Inc., has been named to the National...ent Services,
Scientific Games, Harland Clarke and siga
Technologies is applying viral and bacterial genom...
HHS Secretary Leavitt Announces Members of the National Biodefense Science Board
...er for numerous journals.
Eric A. Rose, M.D.
Dr. Rose is executive vice president for life sciences at MacAndrews &
Forbes Holdings and CEO of siga
Technologies, Inc. He is currently on leave
as professor and chairman of the Department of Surgery at Columbia
University College of Physicians and Su...